News and publications

Patentica at INTA 2025 in San Diego: Join us to discuss IP protection in Eurasia

Dear colleagues, we are pleased to announce our participation in the INTA Annual Meeting on May 17-21, 2025, which is one of the largest events for patent and trademark professionals worldwide.

As a global intellectual property firm, it is very important for us to be aware of IP practices and challenges in different jurisdictions. In turn, we are ready to share our 28-year experience and recent insights on patent and trademark protection in the Eurasian region:

  • Cost-effective IP strategies for national/regional phases in Eurasian countries;
  • IP Court cases and practical approaches to IP litigation;
  • Trademark enforcement, cancelling and protection;
  • Case law in pharma sector: patent linkage, data exclusivity, compulsory licensing, patent term extension;
  • Patentability of IT and AI solutions;
  • Combating counterfeiting for International companies in the region, and many more.

If you are interested to meet our delegates:

  • Victor Lisovenko (Patent Attorney at pharma and chemistry, Lawyer, Co-managing Partner)
  • Elena Dmitrenko (Patent and Trademark Attorney, Lawyer, Partner)
  • Olga Gribanova (Head of the Trademark Department, Trademark Attorney, Partner)
  • Vasiliy Bykov (Patent Attorney at chemistry and biology, Partner),

please contact us to schedule a meeting.

We are also ready to answer your questions and discuss potential collaborations at info@patentica.com.

pat

Recent Posts

Russia modernizes IP law for software-implemented inventions: greater clarity for digital technologies from 2027

Russia is updating its intellectual property legislation to reflect the way modern digital technologies are…

3 недели ago

Eurasian Patent Term Extensions: Patentica’s Guide in The Patent Lawyer Magazine

Patentica is proud to announce that our Eurasian patent attorneys, Ekaterina Petrova and Victor Lisovenko,…

1 месяц ago

Pharmaceutical innovation in Eurasia: AstraZeneca registers a new medicine in Russia

AstraZeneca has registered Baxfendi (baxdrostat) in Russia for the treatment of arterial hypertension. The medicine…

1 месяц ago

EAPO joins the Hague System: what will change for applicants from October 10, 2026

On July 10, 2026, the Eurasian Patent Organization (EAPO) acceded to the Geneva Act of…

2 месяца ago

Russia and Indonesia strengthen cooperation in intellectual property

Rospatent and Indonesia's Ministry of Law have signed a Memorandum of Understanding (MoU) to expand…

4 месяца ago

Five years of the Eurasian system for the protection of industrial designs

In 2026, the Eurasian industrial design system marks its fifth anniversary. Over the past five…

5 месяцев ago